Literature DB >> 15456818

Selective enhancement of tonic GABAergic inhibition in murine hippocampal neurons by low concentrations of the volatile anesthetic isoflurane.

Valerie B Caraiscos1, J Glen Newell, Kong E You-Ten, Erin M Elliott, Thomas W Rosahl, Keith A Wafford, John F MacDonald, Beverley A Orser.   

Abstract

Volatile (inhaled) anesthetics cause amnesia at concentrations well below those that cause loss of consciousness and immobility; however, the underlying neuronal mechanisms are unknown. Although many anesthetics increase inhibitory GABAergic synaptic transmission, this effect occurs only at high concentrations (>100 microm). Molecular targets for low concentrations of inhaled anesthetics have not been identified. Here, we report that a tonic inhibitory conductance in hippocampal pyramidal neurons generated by alpha5 subunit-containing GABA(A) receptors is highly sensitive to low concentrations of the volatile anesthetic isoflurane (ISO) (25 and 83.3 microm). The alpha5 subunit is necessary for enhancement of the tonic current by these low concentrations of isoflurane because potentiation is absent in neurons from alpha5-/- mice. Furthermore, ISO (25 microm) potentiated recombinant human alpha5beta3gamma2L GABA(A) receptors, whereas this effect was not seen with alpha1beta3gamma2L GABA(A) receptors. These studies suggest that an increased tonic inhibition in the hippocampus may contribute to amnestic properties of volatile anesthetics.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456818      PMCID: PMC6729903          DOI: 10.1523/JNEUROSCI.2063-04.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

1.  Characteristics of concatemeric GABA(A) receptors containing α4/δ subunits expressed in Xenopus oocytes.

Authors:  Hong-Jin Shu; John Bracamontes; Amanda Taylor; Kyle Wu; Megan M Eaton; Gustav Akk; Brad Manion; Alex S Evers; Kathiresan Krishnan; Douglas F Covey; Charles F Zorumski; Joe Henry Steinbach; Steven Mennerick
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

2.  Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia.

Authors:  Monica Beneyto; Andrew Abbott; Takanori Hashimoto; David A Lewis
Journal:  Cereb Cortex       Date:  2010-09-15       Impact factor: 5.357

Review 3.  Using EEG to monitor anesthesia drug effects during surgery.

Authors:  Leslie C Jameson; Tod B Sloan
Journal:  J Clin Monit Comput       Date:  2006-12       Impact factor: 2.502

4.  Shaker-related potassium channels in the central medial nucleus of the thalamus are important molecular targets for arousal suppression by volatile general anesthetics.

Authors:  Maria I Lioudyno; Alexandra M Birch; Brian S Tanaka; Yuri Sokolov; Alan L Goldin; K George Chandy; James E Hall; Michael T Alkire
Journal:  J Neurosci       Date:  2013-10-09       Impact factor: 6.167

Review 5.  GABAA receptor-mediated tonic depolarization in developing neural circuits.

Authors:  Juu-Chin Lu; Yu-Tien Hsiao; Chung-Wei Chiang; Chih-Tien Wang
Journal:  Mol Neurobiol       Date:  2013-09-11       Impact factor: 5.590

Review 6.  New insights in the systemic and molecular underpinnings of general anesthetic actions mediated by γ-aminobutyric acid A receptors.

Authors:  Bernd Antkowiak; Uwe Rudolph
Journal:  Curr Opin Anaesthesiol       Date:  2016-08       Impact factor: 2.706

7.  Potentiation of GABAA receptor activity by volatile anaesthetics is reduced by α5GABAA receptor-preferring inverse agonists.

Authors:  I Lecker; Y Yin; D S Wang; B A Orser
Journal:  Br J Anaesth       Date:  2013-03-27       Impact factor: 9.166

8.  General anesthetic actions on GABA(A) receptors.

Authors:  Paul S Garcia; Scott E Kolesky; Andrew Jenkins
Journal:  Curr Neuropharmacol       Date:  2010-03       Impact factor: 7.363

9.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

10.  Abused inhalants enhance GABA-mediated synaptic inhibition.

Authors:  M Bruce MacIver
Journal:  Neuropsychopharmacology       Date:  2009-06-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.